Memory Problems Linked to Slower Rate of Decline in Alzheimer’s

June is Alzheimer’s and Brain Awareness Month. Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

Translate to Spanish or other 102 languages!

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes
Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC – June is Alzheimer’s and Brain Awareness Month.

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

“What we found out was that people with early memory symptoms alone compared to people with early language problems or visual-spatial problems, they tend to have a slightly slower disease progression in terms of their functional abilities,” explained Jagan Pillai, MD, neurologist for Cleveland Clinic and lead author on the study.

- Advertisement -

Dr. Pillai said those with language problems, spatial ability and judgment issues seemed to be affected more over a period of time – specifically in their daily functional abilities.

He said it seems to make sense since a person with just memory difficulties could find other ways to compensate, like keeping track of what they’re doing by recording themselves or writing down notes. That would then allow them to remain functional.

He also noted that memory difficulties come from another part of the brain than language problems, for example. So, how the disease progresses could be different.

“The portion of the brain that is first impacted by the disease tends to determine the symptoms that goes along with the disease and also the kind of progression from there to other regions,” said Dr. Pillai.

- Advertisement -

Dr. Pillai said having this information available can better help physicians diagnose people and prepare them for the future.

It can also be useful for researchers when it comes to testing different medications to treat Alzheimer’s disease.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Lab-Grown Mini Organs Show Promise in Predicting Breast Cancer Treatment Outcomes

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors. 

STHS Hosting Community Blood Drive Amid National Blood Shortage, August 21st 

The United States is facing a severe blood shortage, prompting the American Red Cross to issue only the second national blood crisis declaration in its history.

Study Points to High Blood Pressure as a Key Factor in Rising Heart Disease Rates

Heart disease is the leading cause of death in the United States according to the Journal of the American College of Cardiology. Its impact extends beyond biology, with social detriments such as food insecurity, socioeconomic status and education influencing outcomes.

Dysfunctional, Not Missing, Immune Cells Explain Skin Cancer Risk in Immunosuppressed Patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.
- Advertisement -